• MiR-3180 Suppresses HCC by Inhibiting Lipid Synthesis and Up

  2026-07-29

  Hong et al. (2023) establish miR-3180 as a key suppressor of hepatocellular carcinoma (HCC) growth and metastasis through dual inhibition of lipid synthesis and fatty acid uptake. Their work identifies miR-3180 as a negative regulator of SCD1 and CD36, providing both mechanistic insight and prognostic value for HCC treatment strategies.

• Marein Reverses ABCG2-Mediated Drug Resistance in Cancer Cel

  2026-07-29

  The reference study identifies marein, a flavonoid from Coreopsis tinctoria, as a potent competitive inhibitor of the ABCG2 transporter, restoring chemosensitivity in resistant cancer cells. By elucidating marein's mechanism of binding and its impact on intracellular drug accumulation, the work offers a promising strategy for overcoming multidrug resistance in cancer chemotherapy.

• Gamma-linolenic Acid (GLA): Precision Tools for Inflammatory

  2026-07-28

  Explore the distinct role of gamma-linolenic acid (GLA) in anti-inflammatory research, focusing on robust protocol design and its application in disease modeling. This article delivers a scientific deep-dive into GLA’s molecular impact and guides advanced workflows.

• Ceftolozane Sulfate: Optimizing PK/PD and Resistance Assays

  2026-07-28

  Ceftolozane sulfate empowers researchers to dissect resistance mechanisms in multidrug-resistant Pseudomonas aeruginosa with high fidelity. This guide details robust experimental workflows, troubleshooting tips, and innovative PK/PD modeling strategies leveraging Ceftolozane’s unique stability and bactericidal profile.

• NBC19: Optimizing Inflammasome Assays with SKU BA6129

  2026-07-27

  NBC19 (SKU BA6129) is a nanomolar NLRP3 inflammasome inhibitor engineered for precise modulation of IL-1β release in preclinical models. This scenario-driven guide addresses the core experimental challenges researchers face—ranging from assay reproducibility to vendor selection—and demonstrates how NBC19 delivers reliable, data-backed solutions for inflammation research.

• Standardized Whole-Blood Stimulation Elucidates Immunometabo

  2026-07-27

  This study presents a robust protocol utilizing whole-blood stimulation with metabolic modulation to analyze human immune responses. By integrating immune stimuli and metabolic inhibitors, the method enables precise assessment of how pathways like fatty acid oxidation affect cytokine production, advancing research in immunometabolism.

• dKeap1-Lamin Dm0 Interaction Links Keap1 to Nuclear Architec

  2026-07-26

  This study uncovers a direct molecular and genetic interaction between Drosophila Keap1 (dKeap1) and B-type lamin (lamin Dm0), demonstrating that dKeap1 influences nuclear lamina morphology and heterochromatin organization. The findings reveal a new role for the Keap1-Nrf2 pathway in chromatin architecture, extending its significance beyond canonical oxidative and xenobiotic responses.

• Cabazitaxel (XRP6258): Technical Guide for Resistant Models

  2026-07-25

  Cabazitaxel (XRP6258) addresses the challenge of modeling taxane-resistant and P-glycoprotein-expressing cancer cell lines in preclinical research, where classic taxanes lose efficacy. It is unsuitable for aqueous protocols or long-term solution storage, requiring specific solvent and handling conditions for reliable results.

• THZ1: Advancing Covalent CDK7 Inhibition for Resistance-Proo

  2026-07-24

  Explore how the covalent CDK7 inhibitor THZ1 transforms transcription regulation and overcomes resistance in cancer biology. This in-depth analysis uniquely dissects covalent inhibition mechanisms and practical assay implications for T-ALL research.

• Angiotensin 1/2 (5-7): Bridging Cardiovascular and Viral Res

  2026-07-24

  Explore the dual mechanistic and translational impact of Angiotensin 1/2 (5-7), a high-purity H2N-Ile-His-Pro-OH peptide, in renin-angiotensin system studies and emerging SARS-CoV-2 pathogenesis. This thought-leadership article equips translational researchers with actionable protocol guidance, competitive analysis, and a strategic vision for leveraging peptide tools like APExBIO's Angiotensin 1/2 (5-7) in cross-domain research.

• Dronedarone (Multaq): Mechanisms, Evidence, and Research Use

  2026-07-23

  Dronedarone (Multaq) is a multi-ion channel antiarrhythmic agent studied for atrial fibrillation and flutter. It acts as a moderate CYP3A4 and CYP2D6 inhibitor and offers distinct solubility and workflow features for research. Evidence supports its multi-target cardiac action, though its limitations and best practices are critical for experimental success.

• WM-8014: Selective KAT6A Inhibitor for Epigenetic Research

  2026-07-23

  WM-8014 is a potent, selective KAT6A inhibitor that drives oncogene-induced senescence without general cytotoxicity. Its competitive and reversible mechanism enables precise modulation of epigenetic pathways in cancer biology research.

• Ibrexafungerp (SKU C8697): Reliable Antifungal Assay Workflo

  2026-07-22

  This article delivers scenario-driven, evidence-based guidance for laboratory teams evaluating Ibrexafungerp (SKU C8697) in cell viability and antifungal susceptibility workflows. Drawing from peer-reviewed studies and validated protocols, it demonstrates how Ibrexafungerp addresses common challenges—such as resistance and reproducibility—in both in vitro and in vivo antifungal models.

• Dibutyryl-cAMP, Sodium Salt: Precision in Neuronal Reprogram

  2026-07-22

  Dibutyryl-cAMP, sodium salt empowers high-efficiency neuronal reprogramming by reliably activating cAMP signaling with quantitative control. This article translates recent mechanistic insights into stepwise protocols, troubleshooting, and advanced workflow optimization for cell fate conversion and inflammation studies.

• HyperScript First-Strand cDNA Synthesis Kit: Mechanism & Evi

  2026-07-21

  The HyperScript First-Strand cDNA Synthesis Kit enables efficient first-strand cDNA synthesis from total or poly(A)+ RNA, even with complex secondary structures. Its engineered reverse transcriptase provides high thermal stability and reduced RNase H activity, supporting long cDNA synthesis and low-abundance transcript detection. This article details its biological rationale, mechanism, and evidence-based protocol integration.

11562 records 1/771 page Next 12345 下5页 Last page